The trademark application Gabapentin Aristo long was filed by Aristo Pharma GmbH, a corporation established under the laws of the Federal Republic of Germany (the "Applicant"). The application was published for oppositions on June 19, 2022, and still open for oppositions.
The application was filed in Swedish (German was selected as the second language).
Goods And Services
The mark was filed in class 5 with following description of goods:
Medicines for human purposes, Pharmaceuticals for human medicines, Especially For the treatment of seizure disorders including neuropathic pain